Alkermes (ALKS) Return on Equity [ROE] (2011 - 2026)
Alkermes (ALKS) recorded Return on Equity [ROE] of -0.02% in Q3 2026, down 20.20 percentage points from 20.18% a year earlier and down 3.73 percentage points from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Alkermes reported Return on Equity [ROE] of 14.72%, down 12.80 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of +25.02 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at 27.52% in FY2024 (-4.15 pp), 31.67% in FY2023 (+46.35 pp), -14.68% in FY2022 (-10.26 pp) and -4.42% in FY2021 (+5.88 pp).
- The Q3 2026 figure is the lowest quarterly Return on Equity [ROE] since Q1 2023.
- On a year-over-year basis, Return on Equity [ROE] has declined for eight consecutive quarters, with an average year-over-year change of -10.74 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 39.17 percentage points in Q1 2024, against a drop of 20.20 percentage points in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 3.71% (Q2 2026), 8.55% (Q1 2026) and 13.60% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | - |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.66% |
| 10 | Alkermes | 7.77 Bn | 5.26 Bn | 385.91 Mn | -0.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -0.02% |
| Jun 30, 2026 | 3.71% |
| Mar 31, 2026 | 8.55% |
| Dec 31, 2025 | 13.60% |
| Sep 30, 2025 | 20.18% |
| Jun 30, 2025 | 22.22% |
| Mar 31, 2025 | 23.70% |
| Dec 31, 2024 | 26.63% |
| Sep 30, 2024 | 25.88% |
| Jun 30, 2024 | 22.75% |
| Mar 31, 2024 | 35.36% |
| Dec 31, 2023 | 27.81% |
| Sep 30, 2023 | 25.78% |
| Jun 30, 2023 | 19.96% |
| Mar 31, 2023 | -3.82% |
| Dec 31, 2022 | -3.18% |
| Sep 30, 2022 | -0.43% |
| Jun 30, 2022 | 2.82% |
| Mar 31, 2022 | 5.75% |
| Dec 31, 2021 | 6.92% |
API Access
Alkermes Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();